🔗 Share this article

Following a hold-up and an unusually contentious session, a government vaccine expert group was set to cast ballots on Friday concerning altering the enduring advisory that every infant be vaccinated against hepatitis B.

Heated Debate and a Postponed Decision

The first day of the assembly on Thursday was characterized by fiery discussion over limiting availability to the hepatitis B vaccine for babies and a choice to delay the ballot by a day to give members more time to scrutinize the phrasing. The panel, which counsels the national health agency on immunization practices, had twice before postponed.

“Is there any specific evidence of damage of giving this vaccination before 30 days? Or is this theory?” questioned one adviser.

In reply, another member stated, “There is scant proof about the enduring danger.”

Present Protocol and Potential Impact

The injection is currently recommended for all infants within 24 hours of being born to prevent infection of hepatitis B, which can lead to significant hepatic injury. It has been administered to over a billion individuals for over thirty years.

The meeting in Atlanta provided no fresh data of damage attributable to the vaccine. Experts say any modification to the current hepatitis B vaccination schedule could have profound and widespread implications for childhood health in the United States.

Committee Makeup and Recent Changes

The expert committee can only provide advice to the head of the CDC. The panel's membership has seen shifts recently, with the statement that the committee’s most recent chair would depart for an official role and be substituted with a heart specialist who has been critical of other immunizations.

The committee includes multiple vaccination critics who are in agreement with a goal to reform – and potentially, in some cases, scrap – traditional immunization guidelines.